[
  {
    "text": "1.3 \"Aimmune Agreement Entities\"' means Aimmune's Affiliates and Sublicensees (excluding distributors)",
    "bbox": [
      157,
      83,
      942,
      95
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.4 \"Aimmune Common Stock'' means Aimmune's common stock, par value $0.0001 per share",
    "bbox": [
      157,
      114,
      847,
      125
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.5 \"Aimmune Field' means the field of [***].",
    "bbox": [
      156,
      144,
      497,
      157
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.6 \"Aimmune Invention' means an Invention that is Invented, solely or jointly with a Third Party, by or on behalf of Aimmune or its Affiliates.",
    "bbox": [
      156,
      176,
      1000,
      188
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.7 \"Aimmune Know-How\" means any and all Know-How, whether or not patented or patentable, that is Controlled by Aimmune or its Affiliates as",
    "bbox": [
      157,
      207,
      1000,
      219
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "of the Effective Date or at any time during the Term that is necessary or reasonably useful in connection with the Development, Manufacture,",
    "bbox": [
      110,
      222,
      1000,
      235
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Commercialization or other use of the Antibody or Product.",
    "bbox": [
      111,
      239,
      541,
      250
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.8 \"Aimmune Patent'' means any Patent that (i) (a) is Controlled by Aimmune (or its Affiliates) as of the Effective Date or comes under the",
    "bbox": [
      156,
      269,
      1000,
      281
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Control of Aimmune (or its Affiliates) during the Term (other than as a result of the licenses granted by Xencor to Aimmune under this Agreement) and",
    "bbox": [
      111,
      285,
      1000,
      297
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(b) that would be infringed by the Development, Manufacture, Commercialization or use of the Antibody or Product or that claims or Covers Aimmune",
    "bbox": [
      114,
      302,
      1000,
      312
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Know-How, or (ii) is an Aimmune Collaboration Patent.",
    "bbox": [
      113,
      318,
      509,
      327
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.9 \"Aimmune Technology' means Aimmune Know-How and Aimmune Patents.",
    "bbox": [
      156,
      346,
      746,
      359
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.10 \"Antibody' means Xencor's humanized antibody known as XmAb7195 having the sequence listed in Schedule 1.10.",
    "bbox": [
      157,
      378,
      1000,
      390
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.11 \"Anti-Corruption Laws\" means the U.S. Foreign Corrupt Practices Act, as amended, the UK Bribery Act 2010, as amended, as well as",
    "bbox": [
      156,
      408,
      1000,
      421
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Applicable Law related to the prevention of fraud, racketeering, money laundering or terrorism.",
    "bbox": [
      113,
      426,
      801,
      438
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.12 \"Applicable Law\"' means any applicable United States federal, state or local or foreign or multinational law, statute, standard, ordinance, code,",
    "bbox": [
      155,
      455,
      1000,
      468
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "rule, regulation, resolution or promulgation, or any order, writ, judgment, injunction, decree, stipulation, ruling, determination or award entered by or with",
    "bbox": [
      111,
      472,
      1000,
      484
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "any Governmental Authority, or any license, franchise, permit or similar right granted under any of the foregoing, or any similar provision having the force",
    "bbox": [
      111,
      487,
      1000,
      499
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "or effect of law. For the avoidance of doubt, any specific references to any Applicable Law or any portion thereof, shall be deemed to include all then-",
    "bbox": [
      110,
      502,
      1000,
      515
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "current amendments thereto or any replacement or successor law, statute, standard, ordinance, code, rule, regulation, resolution, order, writ, judgment",
    "bbox": [
      111,
      519,
      1000,
      531
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "injunction, decree, stipulation, ruling, or determination thereto.",
    "bbox": [
      111,
      534,
      566,
      545
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "2",
    "bbox": [
      665,
      550,
      678,
      560
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "SourCe: AIMMUNE THERAPEUTICS, INC., 8-K, 2/5/2020",
    "bbox": [
      133,
      1000,
      574,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  }
]